Prosecution Insights
Last updated: April 19, 2026

Neogap Therapeutics AB

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
19317328 T-CELL EXPANSION METHOD AND USES JUEDES, AMY E 1644 Non-Final OA Sep 03, 2025
18003279 IMMUNOTHERAPY JUEDES, AMY E 1644 Non-Final OA Dec 23, 2022
17417601 PHAGOCYTISABLE PARTICLE FOR USE IN THE TREATMENT OR PROPHYLAXIS OF CANCER JOHANSEN, PETER N. 1644 Final Rejection Jun 23, 2021

Managing Neogap Therapeutics AB's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month